(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -4.74%2.51B | 0.47%1.25B | -8.11%2.63B | -6.01%1.24B | -0.37%2.86B | 14.32%1.32B | -18.89%2.87B | -44.94%1.16B | 2.10%3.54B | 25.09%2.1B |
Operating income | -4.74%2.51B | 0.47%1.25B | -8.11%2.63B | -6.01%1.24B | -0.37%2.86B | 14.32%1.32B | -18.89%2.87B | -44.94%1.16B | 2.10%3.54B | 25.09%2.1B |
Cost of sales | 3.90%-2.19B | -2.52%-1.09B | 6.58%-2.28B | 4.59%-1.07B | -3.25%-2.44B | -17.56%-1.12B | 17.61%-2.36B | 43.99%-950.67M | -2.49%-2.87B | -25.27%-1.7B |
Operating expenses | 3.90%-2.19B | -2.52%-1.09B | 6.58%-2.28B | 4.59%-1.07B | -3.25%-2.44B | -17.56%-1.12B | 17.61%-2.36B | 43.99%-950.67M | -2.49%-2.87B | -25.27%-1.7B |
Gross profit | -10.15%316.52M | -11.80%157.39M | -16.90%352.29M | -13.68%178.45M | -17.10%423.92M | -0.54%206.72M | -24.32%511.37M | -48.92%207.84M | 0.49%675.7M | 24.34%406.92M |
Selling expenses | -11.71%-56.02M | 2.56%-25.75M | 30.35%-50.15M | 18.57%-26.42M | -18.51%-71.99M | -8.77%-32.45M | 0.32%-60.75M | 9.97%-29.83M | -10.56%-60.95M | -26.07%-33.13M |
Administrative expenses | -16.20%-44.93M | -12.87%-22.42M | 7.26%-38.67M | 6.08%-19.86M | 5.05%-41.69M | 4.43%-21.15M | -2.92%-43.91M | 3.80%-22.13M | 9.71%-42.66M | 4.81%-23M |
Research and development expenses | -13.19%-50.02M | -3.66%-23.71M | 23.99%-44.2M | 25.59%-22.88M | 3.77%-58.15M | -6.88%-30.74M | 2.45%-60.42M | 5.72%-28.76M | -6.17%-61.94M | -14.83%-30.51M |
Impairment and provision | 18.81%-165.55M | -87.79%-23.79M | -942.15%-203.9M | 62.35%-12.67M | 105.53%24.21M | 85.42%-33.65M | -726.38%-438.14M | -827.06%-230.73M | 11.55%-53.02M | 39.19%-24.89M |
-Impairment of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---92.37M | ---- | ---- | ---- |
-Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---156.53M | ---94.31M | ---- | ---- |
-Other impairment is provision | 18.81%-165.55M | -87.79%-23.79M | -942.15%-203.9M | 62.35%-12.67M | 112.79%24.21M | 75.33%-33.65M | -256.94%-189.25M | -448.13%-136.42M | 11.55%-53.02M | 39.19%-24.89M |
Special items of operating profit | 32.31%29.1M | -15.45%9.29M | 15.97%21.99M | 55.92%10.99M | 22.00%18.96M | -0.14%7.05M | -35.41%15.54M | -47.48%7.06M | -28.04%24.07M | -32.30%13.44M |
Operating profit | -22.14%29.1M | -34.01%71.02M | -87.34%37.37M | 12.35%107.61M | 486.96%295.26M | 199.21%95.79M | -115.86%-76.3M | -131.26%-96.55M | -0.82%481.2M | 34.76%308.83M |
Financing cost | 11.65%-54.52M | 12.95%-27.52M | 5.60%-61.71M | 2.48%-31.62M | 2.10%-65.37M | 2.69%-32.42M | -3.05%-66.77M | 3.84%-33.32M | 11.94%-64.79M | -6.84%-34.65M |
Earning before tax | -4.48%-25.42M | -42.77%43.5M | -110.58%-24.33M | 19.94%76M | 260.69%229.9M | 148.79%63.37M | -134.36%-143.07M | -147.37%-129.87M | 1.17%416.4M | 39.36%274.18M |
Tax | 108.98%2.88M | 65.78%-9.01M | -42.79%-32.03M | -151.48%-26.32M | -705.40%-22.43M | -346.51%-10.47M | 106.45%3.71M | 110.45%4.25M | 13.15%-57.44M | -33.24%-40.65M |
After-tax profit from continuing operations | 60.00%-22.55M | -30.57%34.49M | -127.17%-56.36M | -6.09%49.68M | 248.87%207.47M | 142.11%52.9M | -138.82%-139.36M | -153.79%-125.62M | 3.91%358.97M | 40.48%233.53M |
Earning after tax | 60.00%-22.55M | -30.57%34.49M | -127.17%-56.36M | -6.09%49.68M | 248.87%207.47M | 142.11%52.9M | -138.82%-139.36M | -153.79%-125.62M | 3.91%358.97M | 40.48%233.53M |
Profit attributable to shareholders | 60.00%-22.55M | -30.57%34.49M | -127.17%-56.36M | -6.09%49.68M | 248.87%207.47M | 142.11%52.9M | -138.82%-139.36M | -153.79%-125.62M | 3.91%358.97M | 40.48%233.53M |
Basic earnings per share | 60.00%-0.0126 | -30.32%0.0193 | -127.20%-0.0315 | -6.10%0.0277 | 248.84%0.1158 | 142.08%0.0295 | -138.82%-0.0778 | -0.0701 | 3.94%0.2004 | |
Diluted earnings per share | 142.08%0.0295 | -138.82%-0.0778 | -153.76%-0.0701 | 3.94%0.2004 | 40.52%0.1304 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data